Ing Investment Management »

Zenas Biopharma shares owned by Ing Investment Management

Quarter-by-quarter ownership of Zenas Biopharma (ZBIO) shares owned by Ing Investment Management from 13F filings

Historical chart of Ing Investment Management investment in Zenas Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Zenas Biopharma held by Ing Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zenas Biopharma by Ing Investment Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $535k 15k 36.31

More positions owned by Ing Investment Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Wisdomtree Tr Voya Yld Enhncd (UNIY)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Lam Research Corp Com New (LRCX)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Wells Fargo & Company (WFC)

View all positions for Ing Investment Management

Top funds holding Zenas Biopharma

Sr One Capital Management
FMR
Enavate Sciences GP
NEA Management Company
Federated Investors
Fairmount Funds Management
NVP Associates
BlackRock
Vanguard Group
Novo A/S
Polar Capital Holdings
Wellington Management Company
Vivo Capital
Arrowpoint Asset Management
EcoR1 Capital

View all funds holding Zenas Biopharma